Special Issues
Table of Content

Advanced Cell Signaling Pathways in Health and Disease

Submission Deadline: 30 April 2026 View: 978 Submit to Special Issue

Guest Editors

Prof. Dr. Ralf Weiskirchen

Email: rweiskirchen@ukaachen.de

Affiliation: Institute of Molecular Pathobiochemistry, Experimental Gene Therapy and Clinical Chemistry (IFMPEGKC), Medical Faculty, RWTH Aachen University, 52074, Aachen, Germany

Homepage:

Research Interests: TGF-β, PDGF, BMPs, gene therapy, liver pathology, hepatocellular carcinoma, animal models, biomarkers

图片4.png


Summary

Cell signaling is crucial for cellular behavior, development, and adaptation. Our understanding of signaling cascades has grown significantly in recent decades, revealing a complex network of molecular events that control processes such as proliferation, differentiation, apoptosis, immune responses, and metabolic regulation. Disruptions in these pathways can lead to various diseases, including cancer, neurodegeneration, metabolic disorders, and autoimmune conditions. In this context, BIOCELL is inviting contributions to a special issue on "Advanced Cell Signaling Pathways in Health and Disease", aiming to highlight cutting-edge discoveries at the cellular level that illuminate the mechanisms, functions, and therapeutic potentials of signaling networks.

This special issue will concentrate on the latest breakthroughs in deciphering signal transduction mechanisms, focusing on their roles in both physiological and pathological contexts. Subtopics of interest include (but are not limited to):
1. Novel Pathways and Crosstalk Mechanisms: Research exploring newly identified signaling pathways or uncharacterized interactions between canonical pathways like MAPK, PI3K/AKT, Notch, Wnt, or TGF-β, especially in dynamic cellular environments.
2. Spatiotemporal Dynamics of Signaling Events: Studies that reveal how the localization and timing of signaling molecules contribute to specific cellular outcomes, including live-cell imaging studies, biosensor-based analyses, or single-cell signaling heterogeneity.
3. Signaling in Stem Cell Fate and Differentiation: Investigations into how signaling networks guide pluripotency, lineage commitment, or reprogramming, particularly under physiological conditions or during tissue regeneration.
4. Signal Transduction in Immune Surveillance and Inflammation: Articles uncovering how immune cells sense and respond to their microenvironment through complex signaling networks, and how dysregulation leads to chronic inflammation or immune evasion in disease.
5. Oncogenic Signaling Networks: Mechanistic studies of how mutations or epigenetic alterations impact signaling cascades to promote tumor initiation, progression, and resistance to therapy.
6. Targeting Cell Signaling for Therapy: Work focused on pharmacological modulation of signaling pathways, including the development of inhibitors, degraders, or RNA-based therapeutics that operate with cell-specific precision.

By bringing together these diverse aspects of signaling research, this special issue aims to offer a comprehensive platform for understanding how signal transduction influences cellular function and dysfunction. We particularly encourage studies that provide novel mechanistic insights or therapeutic implications based on robust cellular models or systems biology approaches.


Keywords

cell signaling, signal transduction, molecular networks, spatiotemporal dynamics, crosstalk mechanisms, stem cell fate, immune surveillance, oncogenic signaling, metabolic regulation, chronic inflammation, pharmacological modulation, therapeutic targeting, rna-based therapeutics, systems biology approaches, disease models and biomarkers

Published Papers


  • Open Access

    REVIEW

    How Do LncRNAs Talk to miRNAs? Decoding Their Dialogue in Atherosclerosis

    YATING WEI, HONGKANG YAO, XIAN SHI, HONG CHEN, RONGZONG YE, CHAOQIAN LI
    BIOCELL, DOI:10.32604/biocell.2025.072780
    (This article belongs to the Special Issue: Advanced Cell Signaling Pathways in Health and Disease)
    Abstract Atherosclerosis, characterized by the formation of fibrofatty lesions in the arterial wall, remains a leading cause of global morbidity and mortality. Emerging evidence highlights the critical regulatory roles of long non-coding RNAs (lncRNAs) and microRNAs (miRNAs) in atherogenesis. LncRNAs can function as competing endogenous RNAs (ceRNAs) by sponging miRNAs, thereby modulating the expression of downstream target mRNAs. This review summarizes current knowledge on lncRNA-miRNA-mRNA regulatory networks and their functional roles in the three major cell types involved in atherosclerotic plaque development: endothelial cells (ECs), vascular smooth muscle cells (VSMCs), and macrophages. In ECs, these networks More >

  • Open Access

    RNF213 Formed and Decorated Membrane-Based Structures in U-2 OS Cells

    TOSHIYUKI HABU
    BIOCELL, DOI:10.32604/biocell.2025.071798
    (This article belongs to the Special Issue: Advanced Cell Signaling Pathways in Health and Disease)
    Abstract RING protein 213 (RNF213), the susceptibility gene for Moyamoya disease (MMD), possesses two active AAA+ ATPase (ATPases Associated with diverse cellular Activities) modules, a RING, and RNF213-ZNFX1 finger (RZ finger) domains. Several RNF213 variants have been reported in MMD patients, including the p.R4810K variant (rs112735431), which is a founder polymorphism associated with MMD in East Asia. To elucidate the function of RNF213 and its variant, we investigated the localization of RNF213 and the R4810K variant in this study. RNF213 induced circular hole structures near the nucleus, similar to lipid droplets (LDs), in U-2 OS cells. More >

Share Link